Chao-wu Li

Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma

Liangyu Li, Zhichao Tian, Huimin Liu, 2020, Investigational New Drugs.

Lack of Influence of XRCC 1 and XPD Gene Polymorphisms on Outcome of Platinum-based Chemotherapy for Advanced Non Small Cell Lung Cancers

Jin-hai Tang, Xin-en Huang, Chao-wu Li, 2010 .

Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis

Zhiru Li, Chao-wu Li, Ting Liu, 2022, BMC cancer.

Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.

Jin-hai Tang, Xin-en Huang, Chao-wu Li, 2009, Asian Pacific journal of cancer prevention : APJCP.

Safety and Efficacy of PD-1 Inhibitors Plus Chemotherapy in Advanced Soft Tissue Sarcomas: A Retrospective Study

Fan Zhang, Peng Zhang, Jiaqiang Wang, 2020, Cancer management and research.

Weekly paclitaxel/ docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication.

Wei Jiang, Y. Shu, Qian Zhang, 2009, Asian Pacific journal of cancer prevention : APJCP.

A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).

W. Mao, Chao-wu Li, Pengfei Xu, 2022, Journal of Clinical Oncology.

Efficacy and safety of sintilimab plus doxorubicin in advanced soft tissue sarcoma: A single-arm, phase II trial

P. Zhang, Fan Zhang, Po Li, 2022, Frontiers in Pharmacology.

A phase 1/2 trial of ORIN1001, a first-in-class IRE1 inhibitor, in patients with advanced solid tumors.

A. Hui, A. Elias, Wei Li, 2022, Journal of Clinical Oncology.